Skip to content
tilman_schoening2_bw

Affiliation

Heidelberg University Hospital Center

Country

Germany

1. Current Status, Position

  • Deputy Head of Pharmacy Department since 2009. Dr Schoening is in charge of Oncology Pharmacy Unit together with central preparation unit of cytotoxic drugs
  • Pharmaceutical management of clinical studies phase I-III in accordance to GCP and GMP
  • Quality management representative
  • Lecturer of clinical pharmacy in the School of Pharmacy
  • Lecturer of pharmacology in the School of Nursing

2. Education

  • 2000 (2nd of June): Licensure as Pharmacist
  • 2001-2009: PhD (Dr. sc. hum.), University of Heidelberg
    – Thesis: “Antimicrobial susceptibility of clinical Group-B-streptococci isolates and molecular typing of resistant strains from two different german regions”
    – examination 2009
  • Since 2004: Specialist in Hospital Pharmacy (“Klinische Pharmazie”, PharmD)
  • Member of the Clinical Pharmacy Board of ADKA (German Association of Hospital Pharmacists)
  • Spokesman of the Oncology Board of ADKA
  • Vice President German Association of Oncology Pharmacy (DGOP)

3. Research Area

Dr Schoening is specialized in Oncology Pharmacy. In particular cytotoxic drugs and renal insufficiency, computerized physician order entry systems and standardization of supportive measures in oncology

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.